Search
for
Sort by
Research 91–120 of 258
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas
- Electron beam tomography quantitation of coronary calcium and assessment for ischemic coronary disease: a complement to stress testing
- 169 Red Sky in Morning: A Case of Concurrent Hematospermia and Anorgasmia
- Finasteride Induced Gynecomastia
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- (192) Evaluating Effect of hCG and hCG+rFSH Therapy on Ejaculation Disorders in Middle-Aged Men: A Case Study
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Male Sex Hormones in Andrology Today
- Finasteride in Androgenic Alopecia
- Post‐finasteride syndrome: real or myth?
- Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
- Post-finasteride syndrome
- ‘Post-finasteride syndrome’: what to tell our female patients?
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- “Acute Pancreatitis Following Finasteride Toxicity: A Rare Case Report"
- Total prostate volume as risk factor for semen pathologies in ageing male
- Molecular genetics of androgen insensitivity
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- A review of the treatment of male pattern hair loss
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- 5α-Reductase inhibitors in androgenetic alopecia
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia